This European expert consensus statement provides recommendations for the diagnosis
and management of primary hyperparathyroidism (PHPT), chronic hypoparathyroidism in …

The purpose of this review is to assess the most recent evidence in the management of
primary hyperparathyroidism (PHPT) and provide updated recommendations for its …

Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem.
The purpose of this report is to provide an update on the use of diagnostic tests for this …

Hungry bone syndrome (HBS) refers to the rapid, profound, and prolonged hypocalcaemia
associated with hypophosphataemia and hypomagnesaemia, and is exacerbated by …

Objective: Asymptomatic primary hyperparathyroidism (PHPT) is a common clinical problem.
The only available definitive therapy is parathyroidectomy, which is appropriate to consider …

Context: Several studies define optimal serum 25-hydroxyvitamin D (25-OHD) levels based
on serum PTH level reaching an asymptote. However, results differ widely, ranging from 25 …

Mild primary hyperparathyroidism (PHPT) is known to affect the skeleton, even though
patients usually are asymptomatic. Treatment strategies have been widely discussed …

Measurements of bone markers (BMs) in peripheral blood or urine are a pivotal part of bone
research within modern clinical medicine. In recent years the use of BMs increased …

Context: Mild primary hyperparathyroidism (PHPT) is a common disease especially in
middle-aged and elderly women. The diagnosis is frequently made incidentally and …

BACKGROUND: There are no large-scale epidemiological studies on primary
hyperparathyroidism (PHPT) in Russia. The high prevalence of the disease, the high risk of …